Brian P Booth
Overview
Explore the profile of Brian P Booth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
631
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xia H, Booth B, Wang Y, Fan C, Bhatnagar V, Kluetz P, et al.
J Patient Rep Outcomes
. 2023 Nov;
7(1):116.
PMID: 37975967
Background: This proof-of-concept retrospective case study investigated whether patient-reported outcomes (PRO) instruments, designed to capture symptomatic adverse event data, could identity a known exposure-response (ER) relationship for safety characterized in...
2.
Wickremsinhe E, Ji Q, Gleason C, Anderson M, Booth B
AAPS J
. 2020 Oct;
22(6):135.
PMID: 33098040
The microsampling workshop generated recommendations pertaining to blood sampling site (venous blood versus capillary blood), when to conduct a bridging study, statistical approaches to establish correlation/concordance and deciding on sample...
3.
4.
Li H, Yu J, Liu C, Liu J, Subramaniam S, Zhao H, et al.
J Pharmacokinet Pharmacodyn
. 2017 Jun;
44(5):403-414.
PMID: 28573468
Pembrolizumab is a monoclonal antibody that targets the programmed death-1 receptor to induce immune-mediated clearance (CL) of tumor cells. Originally approved by the US Food and Drug Administration in 2014...
5.
Gao H, Jacobs A, White R, Booth B, Obach R
AAPS J
. 2013 Jul;
15(4):970-3.
PMID: 23821354
In the 2012 AAPS metabolites in safety testing (MIST) symposium held in Chicago, IL, USA, on October 15, 2012, regulatory experts and industrial scientists joined together to discuss their perspectives...
6.
DeMuth J, Ji Q, Booth B, Fluhler E, Greathead R, Ho S, et al.
Bioanalysis
. 2012 Nov;
4(21):2557-61.
PMID: 23173791
This University of Wisconsin School of Pharmacy bioanalytical conference is presented each year by the Extension Services in Pharmacy, the professional development department within the School. The purpose of this...
7.
Grillo J, Zhao P, Bullock J, Booth B, Lu M, Robie-Suh K, et al.
Biopharm Drug Dispos
. 2012 Jan;
33(2):99-110.
PMID: 22270945
Background: Rivaroxaban is an oral Factor Xa inhibitor. The primary objective of this communication was to quantitatively predict changes in rivaroxaban exposure when individuals with varying degrees of renal impairment...
8.
2011 White paper on recent issues in bioanalysis and regulatory findings from audits and inspections
Garofolo F, Rocci Jr M, Dumont I, Martinez S, Lowes S, Woolf E, et al.
Bioanalysis
. 2011 Sep;
3(18):2081-96.
PMID: 21942519
The 5th Workshop on Recent Issues in Bioanalysis (WRIB) was organized by the Calibration and Validation Group as a 2-day full immersion workshop for pharmaceutical companies, CROs and regulatory agencies...
9.
Savoie N, Garofolo F, van Amsterdam P, Bansal S, Beaver C, Bedford P, et al.
Bioanalysis
. 2010 Nov;
2(12):1945-60.
PMID: 21110739
The 4th Calibration and Validation Group Workshop on Recent Issues in Regulated Bioanalysis, a 2-day full immersion workshop, was organized by the Calibration and Validation Group. Contract research organizations, pharmaceutical...
10.
Savoie N, Booth B, Bradley T, Garofolo F, Hughes N, Hussain S, et al.
Bioanalysis
. 2010 Nov;
1(1):19-30.
PMID: 21083184
This event was organized by the Calibration and Validation Group (a scientific nonprofit organization based in Toronto, Canada) as a 1.5-day workshop for contract research organizations and pharmaceutical companies involved...